Breakthrough Electronic Eye Implant Restores Reading Vision in Blind Patients

Breakthrough in Artificial Vision

A groundbreaking European clinical trial has demonstrated the success of an innovative electronic eye implant in restoring reading vision to patients blinded by age-related macular degeneration (AMD). The PRIMA System, developed by Science Corporation, combines a tiny implant with augmented reality glasses and artificial intelligence to enable sight in previously blind eyes 1

1

2

Source: ScienceDaily

The PRIMA System: How It Works

The PRIMA System consists of three main components:

1. A 2mm x 2mm microchip implant
2. Augmented reality glasses with a video camera
3. A pocket-sized computer with AI algorithms

The procedure begins with a vitrectomy, where surgeons remove the eye's vitreous gel. They then insert the ultra-thin microchip beneath the central retina through a small opening. After the eye heals, patients wear the AR glasses, which capture visual scenes and project them as infrared beams onto the chip. The AI-powered computer processes this data, converting it into electrical signals that travel through the retina and optic nerve to the brain, where they are interpreted as images 1

1

3

Source: Sky News

Impressive Clinical Trial Results

The European trial, involving 38 patients across 17 hospitals in five countries, reported remarkable outcomes:

• 84% of participants regained the ability to read letters, numbers, and words
• Patients could read an average of five lines on a standard vision chart
• Some participants who couldn't see the chart before surgery could now read it
• No significant decline in existing peripheral vision was observed 1

  1

  2

  2

Impact on Patients' Lives

The PRIMA System has been life-changing for many participants. Sheila Irvine, a patient at Moorfields Eye Hospital, shared her experience: "Before receiving the implant, it was like having two black discs in my eyes, with the outside distorted. Now, I can read prescriptions, do crosswords, and read ingredients on tins" 1

1

3

Related Stories

NIH Scientists Develop Novel Surgical Technique for Multiple Retinal Grafts in AMD Treatment

AI Innovations in Early Detection of Myopic Maculopathy: Protecting Millions from Vision Loss

NIH Scientists Revolutionize Eye Imaging with AI-Enhanced Ophthalmoscopy

Brain-computer interface helps man with paralysis feed himself and regain touch after two years

A New Era in Artificial Vision

Mr. Mahi Muqit, associate professor at the UCL Institute of Ophthalmology and senior vitreoretinal consultant at Moorfields Eye Hospital, who led the UK arm of the trial, stated: "In the history of artificial vision, this represents a new era. Blind patients are actually able to have meaningful central vision restoration, which has never been done before" 2

2

Future Implications

This breakthrough offers hope to millions of people worldwide suffering from geographic atrophy caused by dry AMD, a previously untreatable condition. The success of the PRIMA System paves the way for regulatory approval and broader clinical use. Experts are optimistic that this technology could eventually be offered through healthcare systems like the NHS, potentially transforming the lives of those affected by untreatable blindness 1

1

3